Filing Details
- Accession Number:
- 0001415889-25-005997
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-02-28 16:15:08
- Reporting Period:
- 2025-02-26
- Filing Date:
- 2025-02-28
- Accepted Time:
- 2025-02-28 16:15:08
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1636651 | Ovid Therapeutics Inc. | OVID | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1311404 | A Jeffrey Rona | C/O Ovid Therapeutics Inc. 441 Ninth Avenue New York NY 10001 | Cbfo | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2025-02-26 | 3,902 | $0.56 | 67,973 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person.
Billionaire Hedge Funds
